Valuation: CellaVision AB

Market Cap 4.77B 482M 432M 398M 362M 685M 45.2B 704M 1.9B 24.21B 1.81B 1.77B 76.55B P/E 2026 *
33x
P/E 2027 * 25.6x
Enterprise Value 4.57B 462M 414M 382M 347M 656M 43.31B 675M 1.82B 23.21B 1.73B 1.7B 73.36B EV / Sales 2026 *
5.8x
EV / Sales 2027 * 5.11x
Free-Float
81.06%
Yield 2026 *
1.38%
Yield 2027 * 1.6%
1 day+1.13%
1 week+6.28%
Current month+3.78%
1 month+24.39%
3 months+33.20%
6 months+68.89%
Current year+29.13%
1 week 189.2
Extreme 189.2
205
1 month 160.6
Extreme 160.6
205
Current year 117.6
Extreme 117.6
205
1 year 117.6
Extreme 117.6
205
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
399.2
10 years 77.75
Extreme 77.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
9/14/26 A Buy

Chief Executive Officer

8,077 0.0339%
9/2/26 A Free 100,000 0.4193%
4/28/26 A Don

Founder

76,434 0.3205%
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%+6.28%+26.88%+29.63% 486M
-0.65%+2.53%+24.23%+59.67% 267B
-0.04%+1.96%+11.11%+19.10% 165B
-2.96%+1.37%-22.46%+61.01% 160B
-0.10%+1.00%-56.46%-14.79% 63.81B
-1.23%+8.67%+23.03%+61.10% 60.21B
-0.51%-0.95%-0.97%-9.81% 53.82B
-1.12%+1.39%+21.55%+64.01% 50.8B
-1.43%+0.34%+2.87%+84.30% 49.61B
-0.51%+2.87%+25.63%+84.86% 46.83B
Average -0.73%+3.91%+5.54%+43.91% 92B
Weighted average by Cap. -0.99%+4.38%+5.35%+46.28%

Financials

2026 *2027 *
Net sales 788M 79.59M 71.38M 65.78M 59.74M 113M 7.46B 116M 314M 4B 299M 292M 12.64B 884M 89.32M 80.1M 73.82M 67.04M 127M 8.37B 130M 352M 4.49B 335M 328M 14.18B
Net income 145M 14.62M 13.11M 12.08M 10.97M 20.77M 1.37B 21.35M 57.65M 734M 54.87M 53.71M 2.32B 187M 18.86M 16.91M 15.59M 14.16M 26.79M 1.77B 27.54M 74.36M 947M 70.78M 69.28M 3B
Net Debt -199M -20.09M -18.02M -16.61M -15.08M -28.54M -1.88B -29.34M -79.23M -1.01B -75.41M -73.81M -3.19B -252M -25.49M -22.86M -21.07M -19.13M -36.21M -2.39B -37.22M -101M -1.28B -95.67M -93.64M -4.05B
Projected Income Statement - Annual - CellaVision AB
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
252
Date Price Change Volume
10/11/26 SEK 203.00 +1.50% 51,940
09/11/26 SEK 200.00 +0.50% 101,211
06/11/26 SEK 199.00 +0.51% 101,652
05/11/26 SEK 198.00 -0.90% 45,583
04/11/26 SEK 199.80 +4.61% 80,842
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - CellaVision AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
200.00SEK
Average target price
198.33SEK
Spread / Average Target
-0.83%
  1. Stock Market
  2. Stocks
  3. CEVI Stock